Australia
June 23, 2010

The Directors of DataDot Technology Limited (ASX:DDT) announce that AgTechnix
Pty Ltd, the joint initiative company owned by DDT and Ipeco Pty Limited, has
entered into a commercial arrangement with GlaxoSmithKline Australia Pty Limited
(GSK) to use IntelliSeed™ on a commercial quantity of poppy seed to be sown by
GSK in the 2010 season.

Intelliseed™ is a patented track and trace technology allowing seeds, grain and
other bulk commodities to be identified accurately and cost effectively, right down to
an individual batch number, so providing both detection of counterfeit target
commodities and a control mechanism for internal or cross border, end-to-end
supply chain management. Counterfeiting results in losses to plant breeders and
agricultural and horticultural producers world-wide.

From Tasmania, GSK supplies approximately 25% of the global poppy market with
opiate derived products from the cultivation of poppies. The decision by GSK to use
IntelliSeed™ will enhance the value of this export product by adding supply chain
security, visibility, seed authentication, “in soil” identification and seeding rate
validation techniques that have been previously unavailable at this level to the global
seed industry.

Mr Ben Bootle, CEO of DDT, said that AgTechnix welcomes the opportunity to
partner the application of IntelliSeed™ with GSK, a recognised in-field technology
leader in commercial poppy production.

Mr Rohan Kile, Crop Supply Manager of GSK, said that IntelliSeed™ is a logical next step in extending the company’s already high service levels to its Tasmanian
network of contracted growers. It will provide seed authentication at all levels of the
supply chain from seed production to final sowing.

Website: http://www.datadotdna.com

Published: June 28, 2010